News & Insights

Welcoming Alife to the Maveron Portfolio

  1. The fertility space is big and growing: the global IVF (this includes fertility treatments and elective egg freezing) market set to reach $37B in four years
  2. The category has a strong supply and demand mismatch with opportunity to thoughtfully expand supply: There are 450 IVF clinics in the U.S. supporting over 60,000 IVF births a year. Good clinics are overbooked with long wait times. Increasing supply by making existing clinics more productive without compromising quality is key
  3. There is a clear technological Why Now for how Alife can exist today: advances in computer vision and AI, coupled with a growing international data set around IVF, allows for technological intervention to optimize the process

back to insights & news